A failed Soviet Venus probe is expected to fall to Earth today, but when and where? Here's what we know CBS explains decision to cancel The Equalizer and FBI spin-offs: ‘It’s not easy’ Tesla ...

A combination of three drugs — one of them the experimental therapy CuATSM — may be effective for treating amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene, according to a new ...

While misfolded SOD1 proteins (among others) cause ALS, misfolded amyloid beta oligomers cause Alzheimer’s disease. “These are good proteins gone bad,” Klein said. “They are good proteins, but when ...

An experimental candidate by Ractigen Therapeutics to treat amyotrophic lateral sclerosis (ALS) linked to mutations in the SOD1 gene has shown promising signs of slowed functional decline and stable ...

This Series describes how mutations in SOD1, FUS, C9orf72, and TARDBP can disrupt signalling pathways in the CNS and trigger the deposition of neuropathological inclusions. The Series also covers ...

A team of researchers from the University of Wollongong (UOW) have discovered that a unique trio of medications could hold the key to improved treatment outcomes for hereditary cases of Motor Neurone ...

The findings are detailed in a new paper, "A polytherapy approach demonstrates therapeutic efficacy for the treatment of SOD1 associated amyotrophic lateral sclerosis," published in eBioMedicine.

1 Centre for Neuroscience & Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK Objective To investigate the role of ...

These cases are caused by several inherited factors. The most common is in a gene called SOD1. Specific risk factors for ALS have not been conclusively identified, but research is exploring the ...

You may already be familiar with ALS, especially if you took part in the viral ice bucket challenge to raise awareness of the condition back in 2014. Now the disease, which currently has no cure ...